• Register
  • Login

European Journal of Molecular & Clinical Medicine

  1. Home
  2. STUDY OF THE CLINICAL RISK FACTOR ASSESSMENT USING GESTOSIS SCORE IN EARLY PREDICTION OF PREECLAMPSIA

Current Issue

By Issue

By Author

By Subject

Author Index

Keyword Index

About Journal

Aims and Scope

Editorial Board

Publication Ethics

Indexing and Abstracting

Related Links

FAQ

Peer Review Process

Journal Metrics

News

STUDY OF THE CLINICAL RISK FACTOR ASSESSMENT USING GESTOSIS SCORE IN EARLY PREDICTION OF PREECLAMPSIA

    Author

    • Dr. Ankhi Biswas Dr. Soma Basak Dr. Ashis Kumar Mukhopadhyay Dr. A.S.Lohitha Chowdary
,

Document Type : Research Article

  • Article Information
  • Download
  • Export Citation
  • Statistics
  • Share

Abstract

Hypertensive disorders in pregnancy (HDP) is the spectrum of disorders ranging from already existing chronic hypertension in the index pregnancy to complex multisystem disorder like preeclampsia leading to the complications like eclampsia, HELLP syndrome, acute renal failure, pulmonary edema, stroke and left ventricular failure. Preeclampsia, which affects 5–8% of pregnancies worldwide, is one of the leading causes of maternal and fetal morbidity and mortality.
Aims: The aim of the study is to know the usefulness of Gestosis Score in the early prediction of Hypertensive disorders in pregnancy (HDP)
Materials and Methods: The present study was a Prospective comparative observational study. This Study was conducted from April 2021 to September 2022 at Department of Obstetrics & Gynaecology, Chittaranjan Seva Sadan, College of Obstetrics, Gynaecology and child health.
Result: In our study, higher number of patients had LBW [19 (25.3%)] in group A compared to group B [13 (17.3%)] but it was not statistically significant (p=0.2317).
Conclusion: We found that, significant number of patients from the high-risk group developed thrombocytopenia, elevated transaminases, HELLP and severe hypertension. We also found that risk of IUGR and number of SNCU admission were much higher in group A

Keywords

  • HELLP
  • Hypertensive disorders in pregnancy
  • SNCU and chronic hypertension
  • XML
  • PDF 382.58 K
  • RIS
  • EndNote
  • Mendeley
  • BibTeX
  • APA
  • MLA
  • HARVARD
  • VANCOUVER
    • Article View: 11
    • PDF Download: 75
European Journal of Molecular & Clinical Medicine
Volume 10, Issue 2 - Issue Serial Number 2
January 2023
Page 2404-2411
Files
  • XML
  • PDF 382.58 K
Share
Export Citation
  • RIS
  • EndNote
  • Mendeley
  • BibTeX
  • APA
  • MLA
  • HARVARD
  • VANCOUVER
Statistics
  • Article View: 11
  • PDF Download: 75

APA

Dr. A.S.Lohitha Chowdary, D. A. B. D. S. B. D. A. K. M. (2023). STUDY OF THE CLINICAL RISK FACTOR ASSESSMENT USING GESTOSIS SCORE IN EARLY PREDICTION OF PREECLAMPSIA. European Journal of Molecular & Clinical Medicine, 10(2), 2404-2411.

MLA

Dr. Ankhi Biswas Dr. Soma Basak Dr. Ashis Kumar Mukhopadhyay Dr. A.S.Lohitha Chowdary. "STUDY OF THE CLINICAL RISK FACTOR ASSESSMENT USING GESTOSIS SCORE IN EARLY PREDICTION OF PREECLAMPSIA". European Journal of Molecular & Clinical Medicine, 10, 2, 2023, 2404-2411.

HARVARD

Dr. A.S.Lohitha Chowdary, D. A. B. D. S. B. D. A. K. M. (2023). 'STUDY OF THE CLINICAL RISK FACTOR ASSESSMENT USING GESTOSIS SCORE IN EARLY PREDICTION OF PREECLAMPSIA', European Journal of Molecular & Clinical Medicine, 10(2), pp. 2404-2411.

VANCOUVER

Dr. A.S.Lohitha Chowdary, D. A. B. D. S. B. D. A. K. M. STUDY OF THE CLINICAL RISK FACTOR ASSESSMENT USING GESTOSIS SCORE IN EARLY PREDICTION OF PREECLAMPSIA. European Journal of Molecular & Clinical Medicine, 2023; 10(2): 2404-2411.

  • Home
  • About Journal
  • Editorial Board
  • Submit Manuscript
  • Contact Us
  • Glossary
  • Sitemap

News

 

For Special Issue Proposal : editor.ejmcm21@gmail.com

Newsletter Subscription

Subscribe to the journal newsletter and receive the latest news and updates

© Journal Management System. Powered by ejournalplus